Authors: Ertel, EA Campbell, KP Harpold, MM Hofmann, F Mori, Y Perez-Reyes, E Schwartz, A Snutch, TP Tanabe, T Birnbaumer, L Tsien, RW Catterall, WA

Citation: Ea. Ertel et al., Nomenclature of voltage-gated calcium channels, NEURON, 25(3), 2000, pp. 533-535

Authors: Chavez-Noriega, LE Gillespie, A Stauderman, KA Crona, JH Claeps, BO Elliott, KJ Reid, RT Rao, TS Velicelebi, G Harpold, MM Johnson, EC Corey-Naeve, J

Citation: Le. Chavez-noriega et al., Characterization of the recombinant human neuronal nicotinic acetylcholinereceptors alpha 3 beta 2 and alpha 4 beta 2 stably expressed in HEK293 cells, NEUROPHARM, 39(13), 2000, pp. 2543-2560

Authors: Hans, M Luvisetto, S Williams, ME Spagnolo, M Urrutia, A Tottene, A Brust, PF Johnson, EC Harpold, MM Stauderman, KA Pietrobon, D

Citation: M. Hans et al., Functional consequences of mutations in the human alpha(1A) calcium channel subunit linked to familial hemiplegic migraine, J NEUROSC, 19(5), 1999, pp. 1610-1619

Authors: Williams, ME Washburn, MS Hans, M Urrutia, A Brust, PF Prodanovich, P Harpold, MM Stauderman, KA

Citation: Me. Williams et al., Structure and functional characterization of a novel human low-voltage activated calcium channel, J NEUROCHEM, 72(2), 1999, pp. 791-799

Authors: Hans, M Urrutia, A Deal, C Brust, PF Stauderman, K Ellis, SB Harpold, MM Johnson, EC Williams, ME

Citation: M. Hans et al., Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha(1A)-containing high-voltage-activated calcium channels, BIOPHYS J, 76(3), 1999, pp. 1384-1400